Insulin response to glucose is lower in individuals homozygous for the Arg 64 variant of the β-3-adrenergic receptor

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 11, 2000, Pages 4019-4022

  Walston, J ^a   Silver, K ^a   Hilfiker, H ^a   Andersen, R E ^a   Seibert, M ^a   Beamer, B ^a   Roth, J ^a   Poehlman, E ^a   Shuldiner, A R ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 3 ADRENERGIC RECEPTOR; GLUCOSE; INSULIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HOMOZYGOSITY; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; ARGININE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GENOTYPE; GLUCOSE TOLERANCE TEST; HETEROZYGOTE; HUMANS; INSULIN; LEPTIN; MALE; PHENOTYPE; RECEPTORS, ADRENERGIC, BETA-3; REFERENCE VALUES; VARIATION (GENETICS);

EID: 0034522945     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.11.4019     Document Type: Article

References (44)

1. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults
2. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.
3. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
4. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus
5. Mutations in the insulin receptor gene
6. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA
7. Genetics of diabetes mellitus
8. Candidate genes for type II diabetes mellitus
9. Molecular scanning for mutations in the β 3-adrenergic receptor gene in Nauruans with obesity and non-insulin-dependent diabetes mellitus
10. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β 3-adrenergic-receptor gene
11. Genetic variation in the β 3-adrenergic receptor in Japanese NIDDM patients
12. Association of a polymorphism in the β 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns
13. TRP64ARG β 3-adrenergic receptor and obesity in Mexican Americans
14. Mutation of β 3-adrenergic-receptor gene and response to treatment of obesity
15. A mutation in the β 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects
16. Genetic variation in the β 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity
17. The β 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population
18. The Trp64Arg mutation of the β 3-adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts
19. Role of the β 3-adrenergic receptor locus in obesity and non-insulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair
20. Genetic variation in theβ 3-adrenergic receptor in Japanese NIDDM patients
21. β 3-Adrenoceptor gene variant in obesity and insulin resistance
22. Pharmacological characterization of a recently described human β-3-adrenergic receptor mutant
23. The biochemical effect of the naturally occurring Trp64->Arg mutation on human β 3-adrenoceptor activity
24. Mutated human β3-adrenergic receptor (Trp64Arg) lowers the response to β-3-adrenergic agonist in transfected 3T3-LI preadipocytes
25. Trp64Arg mutation of β 3-adrenoceptor gene deteriorates lipolysis induced by β 3-adrenoceptor agonist in human omental adipocytes
26. Polymorphism of the human β 3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function
27. Modified protocols improve insulin sensitivity estimation using the minimal model
28. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin resistance atherosclerosis study
29. MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test
30. Effect of CL 316,243, a novel β 3-adrenoceptor agonist, on insulin secretion in perfused mouse pancreas
31. Anti-hyperglycaemic action of BRL 26830, a novel β-adrenocepter agonist, in mice and rats
32. β-3-Adrenergic receptors on white and brown adipocytes mediateβ 3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake A study using transgenic and gene knockout mice
33. Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study
34. Concentration-dependent effects of adrenaline on the profile of insulin secretion from isolated human islets of Langerhans
35. Physiology and pathophysiology of insulin secretion
36. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation
37. Chronic exposure to free fatty acid reduces pancreatic β cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation
38. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans
39. Trp64Arg variant of the β 3-adrenoceptor and insulin resistance in obese postmenopausal women
40. Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the β 3-adrenergic receptor gene
41. Role of glucose effectiveness in the determination of glucose tolerance
42. Overestimation of minimal model glucose effectiveness in presence of insulin response is due to under-modeling
43. Plasma and interstitial glucose dynamics after intravenous glucose injection: Evaluation of the single-compartment glucose distribution assumption in the minimal models
44. The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes